Renew Biotechnologies Unifies Wasatch BioLabs and Resonant Under One Brand to Advance Sequencing-Based Diagnostics

Summary

Renew Biotechnologies announced the consolidation of Wasatch BioLabs and Resonant under a unified brand to strengthen its molecular diagnostic technology capabilities. The restructuring aims to improve the transition of advanced sequencing-based diagnostic technologies from discovery to clinical implementation.